OpenURL Connection Search

Select item for more details and to access through your institution.

Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk.
Published in:
2008
By:
- Hoogwerf BJ;
- Doshi KB;
- Diab D;
- Hoogwerf, Byron J;
- Doshi, Krupa B;
- Diab, Dima
Publication type:
journal article
Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study.
Published in:
2007
By:
- Ioachimescu AG;
- Brennan DM;
- Hoar BM;
- Kashyap SR;
- Hoogwerf BJ
Publication type:
Journal Article
Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association.
Published in:
2006
By:
- Bantle JP;
- Wylie-Rosett J;
- Albright AL;
- Apovian CM;
- Clark NG;
- Franz MJ;
- Hoogwerf BJ;
- Lichtenstein AH;
- Mayer-Davis E;
- Mooradian AD;
- Wheeler ML;
- American Diabetes Association
Publication type:
Journal Article
Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group.
Published in:
1996
By:
- Ferris FL III;
- Chew EY;
- Hoogwerf BJ;
- Early Treatment Diabetic Retinopathy Study Research Group;
- Ferris, F L 3rd;
- Chew, E Y;
- Hoogwerf, B J
Publication type:
journal article
Coronary artery bypass graft surgery and cognitive performance.
Published in:
2006
By:
- Dupuis G;
- Kennedy E;
- Lindquist R;
- Barton FB;
- Terrin ML;
- Hoogwerf BJ;
- Czajkowski SM;
- Herd JA;
- Post CABG Biobehavioral Study Investigor
Publication type:
Journal Article
Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
Published in:
1999
By:
- Hoogwerf BJ;
- Waness A;
- Cressman M;
- Canner J;
- Campeau L;
- Domanski M;
- Geller N;
- Herd A;
- Hickey A;
- Hunninghake DB;
- Knatterud GL;
- White C;
- Hoogwerf, B J;
- Waness, A;
- Cressman, M;
- Canner, J;
- Campeau, L;
- Domanski, M;
- Geller, N;
- Herd, A
Publication type:
journal article
Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
Published in:
2011
By:
- Buse JB;
- Bergenstal RM;
- Glass LC;
- Heilmann CR;
- Lewis MS;
- Kwan AY;
- Hoogwerf BJ;
- Rosenstock J
Publication type:
Journal Article
The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.
Published in:
2007
By:
- Zinman B;
- Hoogwerf BJ;
- Durán García S;
- Milton DR;
- Giaconia JM;
- Kim DD;
- Trautmann ME;
- Brodows RG;
- Zinman, Bernard;
- Hoogwerf, Byron J;
- Durán García, Santiago;
- Milton, Denái R;
- Giaconia, Joseph M;
- Kim, Dennis D;
- Trautmann, Michael E;
- Brodows, Robert G
Publication type:
journal article
Assessing global cardiovascular risk to improve health outcomes.
Published in:
2009
By:
- Foody JM;
- Hoogwerf BJ;
- Bakris GL;
- Stein EA
Publication type:
Journal Article
Glycemic control and CVD outcomes: randomized clinical trials in 2008.
Published in:
2008
By:
- Hoogwerf BJ
Publication type:
Journal Article
Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database.
Published in:
2011
By:
- Best JH;
- Hoogwerf BJ;
- Herman WH;
- Pelletier EM;
- Smith DB;
- Wenten M;
- Hussein MA;
- Best, Jennie H;
- Hoogwerf, Byron J;
- Herman, William H;
- Pelletier, Elise M;
- Smith, Daniel B;
- Wenten, Made;
- Hussein, Mohamed A
Publication type:
journal article
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association.
Published in:
2008
By:
- Bantle JP;
- Wylie-Rosett J;
- Albright AL;
- Apovian CM;
- Clark NG;
- Franz MJ;
- Hoogwerf BJ;
- Lichtenstein AH;
- Mayer-Davis E;
- Mooradian AD;
- Wheeler ML;
- American Diabetes Association
Publication type:
Journal Article

Found: 12